Fanconi anemia pathway defects in neoplasia: Cause or effect?

Cancer Biology and Therapy

Volumn 3, Issue 6, 2004, Pages 538-539

  Berleth, Erica S ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Cancer; FANCD2; FANCF; Fanconi anemia; Mitomycin C

Indexed keywords

BRCA2 PROTEIN; COMPLEMENTARY DNA; MITOMYCIN D; FANCD2 PROTEIN, HUMAN; FANCONI ANEMIA GROUP D2 PROTEIN; NUCLEAR PROTEIN; UBIQUITIN;

CANCER CELL CULTURE; CANCER PATIENT; CELL LINE; DISEASE PREDISPOSITION; DNA DAMAGE; ENZYME ACTIVITY; FANCONI ANEMIA; GENE; GENE MUTATION; HUMAN; IMMUNOBLOTTING; NEOPLASM; NOTE; UBIQUITINATION; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; HUMANS; NEOPLASMS; NUCLEAR PROTEINS; SIGNAL TRANSDUCTION; UBIQUITIN;

EID: 21644437787     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.3.6.929     Document Type: Note

References (13)

1. D'Andrea AD, Grompe M. The Fanconi anaemia/BRCA pathway. Nat Rev Cancer 2003; 3:23-34.
2. D'Andrea AD. The Fanconi road to cancer. Gene Dev 2003; 17:1933-6.
3. Alter BP. Cancer in Fanconi anemia, 1927-2001. Cancer 2003; 97:425-40.
4. Houghtaling S, Timmers C, Noll M, Finegold MJ, Jones SN, Meyn MS, et al. Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Gene Dev 2003; 17:2021-35.
5. Hewlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, De Die-Smulders C, et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 2002; 297:606-9.
6. Garcia-Higuera I, Taniguchi T, Ganesan S, et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Molecular Cell 2001; 7(2):249-262.
7. Lorick KL, Jensen JP, Fang S, Ong AM, Hatakeyama S, Weissman AM. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination. Proc Nat Acad Sci USA 1999; 96:11364-9.
8. Vandenberg CJ, Gergely F, Ong CY, Pace P, Mallery DL, Hiom K, et al. BRCA1-independent ubiquitination of FANCD2. Mol Cell 2003; 12:247-54.
9. Meetei AR, de Winter JP, Medhurst AL, Wallisch M, Waisfisz Q, van de Vrugt HJ, et al. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet 2003; 35:165-70.
10. van der Heijden MS, Brody JR, Kern SE. Functional screen of the Fanconi anemia pathway in cancer cells by fancd2 immunoblot. Cancer Biol Ther 2004; In press.
11. Elstner E, Williamson EA, Zang C, Fritz J, Heber D, Fenner M, et al. Novel therapeutic approach: Ligands for PPARγ and retinoid receptors induce apoptosis in bcl-2-positive human breast cancer cells. Breast Cancer Res Treat 2002; 74:155-65.
12. Grossman SR, Deato ME, Brignone C, Chan HM, Kung AL, Tagami H, et al. Polyubiquitination of p53 by a ubiquitin ligase activity of p300. Science 2003; 300:342-4.
13. Taniguchi T, Tischkowitz M, Ameziane N, Hodgson SV, Mathew CG, Joenje H, Mok SC, et al. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors. Nat Med 2003; 9:568-74.